Axelys provides grant funding and technology transfer support through the RNA Entrepreneurship Initiative to accelerate the commercialization of ribonucleic acid research across Québec.
Axelys provides grant funding and technology transfer support through the RNA Entrepreneurship Initiative to accelerate the commercialization of ribonucleic acid research across Québec. The program assists university researchers, academic spinout founders, and biotech startups in transforming laboratory RNA discoveries into market-ready biopharmaceutical solutions. Eligible applicants receive non-repayable financial aid up to $150,000 CAD to complete proof-of-concept testing and establish commercial spinout ventures.
Other programs in the same space.
Natural Resources Canada (NRCan)
Transport Canada
SOCCA
Ulnooweg
